Skip to content

Clinical trials

Autoimmune Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Country / region: Australia Clear all

49 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20101
20111
20122
20132
20141
20161
20171
20181
20193
20202
20215
20221
20234
20246
20256
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting15
Terminated6
Unknown status3
Active, not recruiting2
Not yet recruiting2
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
GlaxoSmithKline2
Immunovant Sciences GmbH2
Otsuka Pharmaceutical Development & Commercialization, Inc.2
Takeda2
Altis Medicines, Inc1
Atara Biotherapeutics1
Athos Therapeutics Inc1
Bayhill Therapeutics1
Beeline Medicines Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases49
Immune System Diseases11
Lupus Erythematosus, Systemic8
Connective Tissue Diseases6
Sjogren's Syndrome6
Hematologic Diseases5
Arthritis, Rheumatoid4
Purpura, Thrombocytopenic, Idiopathic4
Scleroderma, Systemic4
Blood Platelet Disorders3

Trials

Showing 51 to 49 of 49. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.